Clinical trial
3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung…
NCT00064064 · Vion Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00064064 |
|---|---|
| Title | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer |
| Official title | A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | Vion Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, triapine |
| Start date | Jan 1, 2003 |
| Completion | Aug 1, 2008 |
| First posted | Jul 9, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | Netherlands, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: